Navigation Links
FDA Advisory Committee Recommends Approval of Abbott's XIENCE(TM) V Drug Eluting Stent System
Date:11/29/2007

device in the United States and Japan.

About Abbott

Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs 65,000 people and markets its products in more than 130 countries.

Abbott's news releases and other information are available on the company's Web site at http://www.abbott.com


'/>"/>
SOURCE Abbott
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Genaera Announces Formation of Scientific Advisory Board for Obesity Drug Candidate Trodusquemine (MSI-1436)
2. China Holdings Appoints Ronald Shon Chairman of Advisory Board to Its Wholly-Owned Subsidiary China Power, Inc.
3. CryoCor Invited to Participate in FDA Advisory Panel Meeting on Atrial Fibrillation
4. Patient Safety Authority Board of Directors Names Infection Advisory Panel
5. Broker a Suite of Research & Advisory Services to Enhance Human Resources
6. Lynn Clark Callister, National Leader in Maternal-Child Health Nursing, Joins March of Dimes Advisory Council
7. MaxLife Fund Corp. appoints Daniel E. Kahan, to its Advisory Board
8. Delta Dental Plans Association Forms National Scientific Advisory Committee
9. Alter+Care Creates the Advisory Board
10. Patient Safety Authority Releases Advisory Focusing on Common Causes of Medication Errors
11. Susan G. Komen for the Cure Appoints Dr. Amelie G. Ramirez to Scientific Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... Dr. Rod J. Rohrich, Dallas ... the Department of Plastic Surgery at UT Southwestern ... grafting, and modern lift-and-fill facelifts before colleagues at ... by the American Society of Plastic Surgeons (ASPS). ... structure were explored in detail during Dr. Rohrich's ...
(Date:11/26/2014)... By Amy Norton ... -- While people have long believed their dogs understand what ... meaning and emotion of words in a human-like way. ... of human speech -- including the actual content and the ... team,s findings give a deeper insight into the canine brain, ...
(Date:11/26/2014)... Nov. 26, 2014 (HealthDay News) -- More than half ... their thinking and memory skills, a new study suggests. ... Neurology , "approximately 1.8 million Americans over the age ... of their cognitive [mental] abilities," study author Dr. Vikas ... Ann Arbor, said in a journal news release. ...
(Date:11/26/2014)... Deptford, NJ (PRWEB) November 26, 2014 ... and Lourdes Cardiology have launched a partnership designed ... readmission rates for congestive heart failure (CHF) patients ... Deptford Center staff and Lourdes Cardiology team will ... developed and supervised protocols. This partnership pairs the ...
(Date:11/26/2014)... German scientists say carbon-based synthetic molecules used ... that looks and acts similar to asbestos-induced mesothelioma. Surviving ... research. Click here to read it now. ... Experimental Medicine in Hannover injected 500 lab rats with ... eventually developed mesothelioma , how quickly it developed ...
Breaking Medicine News(10 mins):Health News:Dr. Rod J. Rohrich Discusses Facelifts at ASPS Annual Assembly 2Health News:Dr. Rod J. Rohrich Discusses Facelifts at ASPS Annual Assembly 3Health News:Your Dog Really Is Listening to You 2Health News:Your Dog Really Is Listening to You 3Health News:Too Few Americans Undergo Dementia Screening 2Health News:Advanced Heart Failure Recovery Program comes to Deptford Center for Rehabilitation and Healthcare 2Health News:Advanced Heart Failure Recovery Program comes to Deptford Center for Rehabilitation and Healthcare 3Health News:Multi-walled Nanotubes Linked to Mesothelioma in New Study, According to Surviving Mesothelioma 2
... , , NASHVILLE, ... $11.6 and $18 billion in diagnostic imaging costs over the ... program similar to those used in the private sector. Currently, ... billions of dollars. According to an independent analysis released today ...
... , , , ... , , FAIRFAX, Va., July 16 ... a cancer survivor in the Chicago area who has dedicated his or ... winner of the Survivor Circle Award will receive $1,000 and be honored ...
... , The hospital is the highest-rated Illinois ... , CHICAGO, July 16 Northwestern Memorial Hospital is ... ranked in Illinois -- as part of U.S. News & World Report,s 2009 ... guide evaluated 4,861 medical centers nationwide and 174 were chosen and ranked according ...
... get LASIK, researchers say , THURSDAY, July 16 (HealthDay ... surgery may benefit from implantable lenses made of a ... LASIK "has gained widespread popularity as a safe and ... with high [severe] myopia or thin corneas face some ...
... , , , ... www.STDTestExpress.com ) offers leading direct-to-consumer testing services for sexually ... on the Internet to have partnered with a telemedicine network ... to order these specialty tests, discuss STD symptoms, review test ...
... 16 Enigma Diagnostics Limited, the decentralized and point-of-care molecular ... license agreements with Roche Molecular Systems, Inc. (RMS). , ... July 2009, provide Enigma full access under patents owned or ... PCR chemistry and melt analysis and will allow Enigma to ...
Cached Medicine News:Health News:Radiology Benefit Management Could Save Medicare up to $18 Billion Over 10 Years 2Health News:Radiology Benefit Management Could Save Medicare up to $18 Billion Over 10 Years 3Health News:Award Honors Chicago Cancer Survivor Who Gives Back 2Health News:Award Honors Chicago Cancer Survivor Who Gives Back 3Health News:Award Honors Chicago Cancer Survivor Who Gives Back 4Health News:Northwestern Memorial Among America's Best Hospitals in 11 Clinical Specialties According to U.S. News' 2009 Rankings 2Health News:Northwestern Memorial Among America's Best Hospitals in 11 Clinical Specialties According to U.S. News' 2009 Rankings 3Health News:New Option for Correcting Nearsightedness 2Health News:STD Test Express Offers Free Doctor Consultations With Every STD Test 2Health News:Enigma Diagnostics Announces Signing of Patent Licenses With Roche Molecular Systems, Inc. 2
(Date:11/26/2014)... -- Unilife Corporation (NASDAQ: UNIS, ASX: UNS), a designer, manufacturer ... that its Chairman and CEO, Alan Shortall , ... Annual Healthcare Conference at the New York Palace Hotel ... The conference presentation will be broadcast ... To listen, please go to: http://ir.unilife.com/events.cfm . An ...
(Date:11/26/2014)... THOUSAND OAKS, Calif. and LONDON ... AMGN ) and AstraZeneca (NYSE: AZN ) today ... trial evaluating two doses of brodalumab in more than 1,800 ... compared with both Stelara ® (ustekinumab) and placebo at ... the brodalumab weight-based analysis group were each shown to be ...
(Date:11/26/2014)... SAN DIEGO , Nov. 25, 2014 Halozyme ... at the Piper Jaffray Healthcare Conference in New ... p.m. EDT/10:00 a.m. PDT . Dr. Helen Torley ... overview. The presentation will be webcast through the ... and a recording will be made available for 90 days ...
Breaking Medicine Technology:Unilife to Present at the Piper Jaffray 26th Annual Healthcare Conference on December 2nd 2Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 2Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 3Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 4Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 5Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 6Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 7Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 8Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 9Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 10Halozyme Therapeutics To Present At The Piper Jaffray Healthcare Conference 2
... the Study of the ... Liver Annual Meeting -, SAN FRANCISCO, April ... 2 study of its lead,compound, MitoQ(R) (mitoquinone) in liver disease. The results ... of the Liver,(EASL) Annual Meeting, being held April 23 - 27 in ...
... at the 10th Annual Superbugs and Superdrugs Conference on ... ... Mass., April 10 Enanta Pharmaceuticals, a,leader in the development ... breakthrough research program to,evaluate a new macrolide-related drug class, Bicyclolides, ...
Cached Medicine Technology:Antipodean Pharmaceuticals Announces Completion of Phase 2 Study of Lead Compound MitoQ(R) 2Enanta Reports New Macrolide-Related Drug Class, Bicyclolides, to Combat Hospital and Community Acquired Superbug Infections, Including MRSA 2Enanta Reports New Macrolide-Related Drug Class, Bicyclolides, to Combat Hospital and Community Acquired Superbug Infections, Including MRSA 3
Shandon Slide File Storage System...
Shandon Plastic Slide Folders...
Shandon Microscope Slide Cabinet with Drawers...
... containing over 330 species of microorganisms ... Compact offers enhanced identification capabilities. In ... to 14 hours), it identifies the ... production areas and final products., Therefore, ...
Medicine Products: